These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28027885)

  • 1. Structural differences in mixing behavior informing the role of asymptomatic infection and testing symptom heritability.
    Santermans E; Van Kerckhove K; Azmon A; John Edmunds W; Beutels P; Faes C; Hens N
    Math Biosci; 2017 Mar; 285():43-54. PubMed ID: 28027885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who is the infector? Epidemic models with symptomatic and asymptomatic cases.
    Leung KY; Trapman P; Britton T
    Math Biosci; 2018 Jul; 301():190-198. PubMed ID: 29654792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of epidemic models with asymptomatic infection and seasonal succession.
    Tang Y; Xiao D; Zhang W; Zhu D
    Math Biosci Eng; 2017 Oct/Dec 1; 14(5-6):1407-1424. PubMed ID: 29161868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of illness on social networks: implications for transmission and control of influenza.
    Van Kerckhove K; Hens N; Edmunds WJ; Eames KT
    Am J Epidemiol; 2013 Dec; 178(11):1655-62. PubMed ID: 24100954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating contact patterns relevant to the spread of infectious diseases in Russia.
    Ajelli M; Litvinova M
    J Theor Biol; 2017 Apr; 419():1-7. PubMed ID: 28161415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Household members do not contact each other at random: implications for infectious disease modelling.
    Goeyvaerts N; Santermans E; Potter G; Torneri A; Van Kerckhove K; Willem L; Aerts M; Beutels P; Hens N
    Proc Biol Sci; 2018 Dec; 285(1893):20182201. PubMed ID: 30963910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review Article: The Fraction of Influenza Virus Infections That Are Asymptomatic: A Systematic Review and Meta-analysis.
    Leung NH; Xu C; Ip DK; Cowling BJ
    Epidemiology; 2015 Nov; 26(6):862-72. PubMed ID: 26133025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting nonpharmaceutical interventions for influenza.
    Jones RM; Adida E
    Risk Anal; 2013 Aug; 33(8):1473-88. PubMed ID: 23231621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of symptomatic presentation in influenza A transmission risk.
    Wardell R; Prem K; Cowling BJ; Cook AR
    Epidemiol Infect; 2017 Mar; 145(4):723-727. PubMed ID: 27916020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data.
    Cauchemez S; Carrat F; Viboud C; Valleron AJ; Boëlle PY
    Stat Med; 2004 Nov; 23(22):3469-87. PubMed ID: 15505892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian model choice for epidemic models with two levels of mixing.
    Knock ES; O'Neill PD
    Biostatistics; 2014 Jan; 15(1):46-59. PubMed ID: 23887980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity.
    Mathews JD; McCaw CT; McVernon J; McBryde ES; McCaw JM
    PLoS One; 2007 Nov; 2(11):e1220. PubMed ID: 18043733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of a disease outbreak in stochastic multipatch epidemic models.
    Lahodny GE; Allen LJ
    Bull Math Biol; 2013 Jul; 75(7):1157-80. PubMed ID: 23666483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stochastic model of an influenza epidemic with drug resistance.
    Xu Y; Allen LJ; Perelson AS
    J Theor Biol; 2007 Sep; 248(1):179-93. PubMed ID: 17582443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the contribution of asymptomatic infection to the cumulative incidence.
    Champredon D; Moghadas SM
    Epidemiol Infect; 2017 Apr; 145(6):1256-1258. PubMed ID: 28166860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameterizing Spatial Models of Infectious Disease Transmission that Incorporate Infection Time Uncertainty Using Sampling-Based Likelihood Approximations.
    Malik R; Deardon R; Kwong GP
    PLoS One; 2016; 11(1):e0146253. PubMed ID: 26731666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation.
    Hendrickx DM; Abrams S; Hens N
    J Theor Biol; 2019 Sep; 476():5-18. PubMed ID: 31145910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating individual and household reproduction numbers in an emerging epidemic.
    Fraser C
    PLoS One; 2007 Aug; 2(8):e758. PubMed ID: 17712406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Household and community transmission parameters from final distributions of infections in households.
    Longini IM; Koopman JS
    Biometrics; 1982 Mar; 38(1):115-26. PubMed ID: 7082755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time variations in the generation time of an infectious disease: implications for sampling to appropriately quantify transmission potential.
    Nishiura H
    Math Biosci Eng; 2010 Oct; 7(4):851-69. PubMed ID: 21077712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.